GSE,Sample_title,Sample_geo_accession,Sample_status,Sample_submission_date,Sample_last_update_date,Sample_type,Sample_channel_count,Sample_source_name_ch1,Sample_organism_ch1,Sample_taxid_ch1,Sample_treatment_protocol_ch1,Sample_growth_protocol_ch1,Sample_molecule_ch1,Sample_extract_protocol_ch1,Sample_data_processing,Sample_platform_id,Sample_contact_name,Sample_contact_email,Sample_contact_laboratory,Sample_contact_department,Sample_contact_institute,Sample_contact_address,Sample_contact_city,Sample_contact_zip/postal_code,Sample_contact_country,Sample_instrument_model,Sample_library_selection,Sample_library_source,Sample_library_strategy,Sample_series_id,Sample_data_row_count,file,file_url,sample_name,file_size,type,Sample_description,Genome_build,Supplementary_files_format_and_content,cell line,cell type,sirna treatment,sirna concentration,sirna time,hormone treatment,hormone concentration,hormone time,chip antibody,BioSample,SRA
GSE136016,VCaP_AR_EtOH_rep1,GSM4039415,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039415_VCaP_AR_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039415/suppl/GSM4039415_VCaP_AR_EtOH_rep1.bedGraph.gz,VCaP_AR_EtOH_rep1,607336394,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,EtOH vehicle,0.01%,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN12603200,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_EtOH_rep2,GSM4039416,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039416_VCaP_AR_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039416/suppl/GSM4039416_VCaP_AR_EtOH_rep2.bedGraph.gz,VCaP_AR_EtOH_rep2,194684785,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,EtOH vehicle,0.01%,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN12603197,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_DHT_rep1,GSM4039417,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039417_VCaP_AR_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039417/suppl/GSM4039417_VCaP_AR_DHT_rep1.bedGraph.gz,VCaP_AR_DHT_rep1,479193799,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN12603226,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_DHT_rep2,GSM4039418,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039418_VCaP_AR_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039418/suppl/GSM4039418_VCaP_AR_DHT_rep2.bedGraph.gz,VCaP_AR_DHT_rep2,326908252,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN12603225,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_SMARCA4_EtOH_rep1,GSM4039419,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, SMARCA4 ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039419_VCaP_SMARCA4_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039419/suppl/GSM4039419_VCaP_SMARCA4_EtOH_rep1.bedGraph.gz,VCaP_SMARCA4_EtOH_rep1,363718379,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,EtOH vehicle,0.01%,1 h,"SMARCA4 (Abcam, ab110641, lot # GR3208604-11)",https://www.ncbi.nlm.nih.gov/biosample/SAMN12603224,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_SMARCA4_EtOH_rep2,GSM4039420,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, SMARCA4 ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039420_VCaP_SMARCA4_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039420/suppl/GSM4039420_VCaP_SMARCA4_EtOH_rep2.bedGraph.gz,VCaP_SMARCA4_EtOH_rep2,222240738,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,EtOH vehicle,0.01%,1 h,"SMARCA4 (Abcam, ab110641, lot # GR3208604-11)",https://www.ncbi.nlm.nih.gov/biosample/SAMN12603223,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_SMARCA4_DHT_rep1,GSM4039421,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, SMARCA4 ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039421_VCaP_SMARCA4_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039421/suppl/GSM4039421_VCaP_SMARCA4_DHT_rep1.bedGraph.gz,VCaP_SMARCA4_DHT_rep1,196150318,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,dihydrotestosterone,100 nM,1 h,"SMARCA4 (Abcam, ab110641, lot # GR3208604-11)",https://www.ncbi.nlm.nih.gov/biosample/SAMN12603222,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_SMARCA4_DHT_rep2,GSM4039422,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, SMARCA4 ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039422_VCaP_SMARCA4_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039422/suppl/GSM4039422_VCaP_SMARCA4_DHT_rep2.bedGraph.gz,VCaP_SMARCA4_DHT_rep2,272979638,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,dihydrotestosterone,100 nM,1 h,"SMARCA4 (Abcam, ab110641, lot # GR3208604-11)",https://www.ncbi.nlm.nih.gov/biosample/SAMN12603221,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_input_rep1,GSM4039423,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, control ChIP input",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4039423_VCaP_input_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039423/suppl/GSM4039423_VCaP_input_rep1.bedGraph.gz,VCaP_input_rep1,320007679,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,NA,NA,NA,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603220,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siNON_EtOH_rep1,GSM4039424,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siNON, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039424_VCaP_ATAC_siNON_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039424/suppl/GSM4039424_VCaP_ATAC_siNON_EtOH_rep1.bedGraph.gz,VCaP_ATAC_siNON_EtOH_rep1,915509988,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603219,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siNON_EtOH_rep2,GSM4039425,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siNON, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039425_VCaP_ATAC_siNON_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039425/suppl/GSM4039425_VCaP_ATAC_siNON_EtOH_rep2.bedGraph.gz,VCaP_ATAC_siNON_EtOH_rep2,196990527,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603218,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siNON_DHT_rep1,GSM4039426,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039426_VCaP_ATAC_siNON_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039426/suppl/GSM4039426_VCaP_ATAC_siNON_DHT_rep1.bedGraph.gz,VCaP_ATAC_siNON_DHT_rep1,564063663,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603217,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siNON_DHT_rep2,GSM4039427,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039427_VCaP_ATAC_siNON_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039427/suppl/GSM4039427_VCaP_ATAC_siNON_DHT_rep2.bedGraph.gz,VCaP_ATAC_siNON_DHT_rep2,160195024,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603216,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSMARCA4_EtOH_rep1,GSM4039428,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSMARCA4, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039428_VCaP_ATAC_siSMARCA4_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039428/suppl/GSM4039428_VCaP_ATAC_siSMARCA4_EtOH_rep1.bedGraph.gz,VCaP_ATAC_siSMARCA4_EtOH_rep1,527294777,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603215,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSMARCA4_EtOH_rep2,GSM4039429,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSMARCA4, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039429_VCaP_ATAC_siSMARCA4_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039429/suppl/GSM4039429_VCaP_ATAC_siSMARCA4_EtOH_rep2.bedGraph.gz,VCaP_ATAC_siSMARCA4_EtOH_rep2,388541734,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603214,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSMARCA4_DHT_rep1,GSM4039430,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSMARCA4, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039430_VCaP_ATAC_siSMARCA4_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039430/suppl/GSM4039430_VCaP_ATAC_siSMARCA4_DHT_rep1.bedGraph.gz,VCaP_ATAC_siSMARCA4_DHT_rep1,651603882,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603212,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSMARCA4_DHT_rep2,GSM4039431,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSMARCA4, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039431_VCaP_ATAC_siSMARCA4_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039431/suppl/GSM4039431_VCaP_ATAC_siSMARCA4_DHT_rep2.bedGraph.gz,VCaP_ATAC_siSMARCA4_DHT_rep2,249960914,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603211,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSIM2_EtOH_rep1,GSM4039432,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSIM2, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039432_VCaP_ATAC_siSIM2_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039432/suppl/GSM4039432_VCaP_ATAC_siSIM2_EtOH_rep1.bedGraph.gz,VCaP_ATAC_siSIM2_EtOH_rep1,320195671,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603210,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSIM2_EtOH_rep2,GSM4039433,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSIM2, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039433_VCaP_ATAC_siSIM2_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039433/suppl/GSM4039433_VCaP_ATAC_siSIM2_EtOH_rep2.bedGraph.gz,VCaP_ATAC_siSIM2_EtOH_rep2,593971055,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603209,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSIM2_DHT_rep1,GSM4039434,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSIM2, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039434_VCaP_ATAC_siSIM2_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039434/suppl/GSM4039434_VCaP_ATAC_siSIM2_DHT_rep1.bedGraph.gz,VCaP_ATAC_siSIM2_DHT_rep1,126785443,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603207,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_ATAC_siSIM2_DHT_rep2,GSM4039435,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSIM2, ATAC",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,other,genomic,ATAC-seq,GSE136016,0,GSM4039435_VCaP_ATAC_siSIM2_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039435/suppl/GSM4039435_VCaP_ATAC_siSIM2_DHT_rep2.bedGraph.gz,VCaP_ATAC_siSIM2_DHT_rep2,174608775,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603206,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siNON_EtOH_rep1,GSM4039436,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siNON, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039436_VCaP_RNA_siNON_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039436/suppl/GSM4039436_VCaP_RNA_siNON_EtOH_rep1.bedGraph.gz,VCaP_RNA_siNON_EtOH_rep1,82385319,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603205,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siNON_EtOH_rep2,GSM4039437,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siNON, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039437_VCaP_RNA_siNON_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039437/suppl/GSM4039437_VCaP_RNA_siNON_EtOH_rep2.bedGraph.gz,VCaP_RNA_siNON_EtOH_rep2,108106654,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603204,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siNON_EtOH_rep3,GSM4039438,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siNON, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039438_VCaP_RNA_siNON_EtOH_rep3.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039438/suppl/GSM4039438_VCaP_RNA_siNON_EtOH_rep3.bedGraph.gz,VCaP_RNA_siNON_EtOH_rep3,83097948,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603203,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siNON_DHT_rep1,GSM4039439,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039439_VCaP_RNA_siNON_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039439/suppl/GSM4039439_VCaP_RNA_siNON_DHT_rep1.bedGraph.gz,VCaP_RNA_siNON_DHT_rep1,68662381,BEDGRAPH,VCaP_RNA_siNON_DHT_rep2 sample was not used in the downstream analyses due to dissimilarity to other biological replicates. VCaP_RNA_siNON_DHT_rep1 and VCaP_RNA_siNON_DHT_rep3 were used in the downstream analyses.,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603202,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siNON_DHT_rep2,GSM4039440,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039440_VCaP_RNA_siNON_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039440/suppl/GSM4039440_VCaP_RNA_siNON_DHT_rep2.bedGraph.gz,VCaP_RNA_siNON_DHT_rep2,40144994,BEDGRAPH,VCaP_RNA_siNON_DHT_rep2 sample was not used in the downstream analyses due to dissimilarity to other biological replicates. VCaP_RNA_siNON_DHT_rep1 and VCaP_RNA_siNON_DHT_rep3 were used in the downstream analyses.,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603201,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siNON_DHT_rep3,GSM4039441,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039441_VCaP_RNA_siNON_DHT_rep3.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039441/suppl/GSM4039441_VCaP_RNA_siNON_DHT_rep3.bedGraph.gz,VCaP_RNA_siNON_DHT_rep3,77886246,BEDGRAPH,VCaP_RNA_siNON_DHT_rep2 sample was not used in the downstream analyses due to dissimilarity to other biological replicates. VCaP_RNA_siNON_DHT_rep1 and VCaP_RNA_siNON_DHT_rep3 were used in the downstream analyses.,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603199,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSMARCA4_EtOH_rep1,GSM4039442,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSMARCA4, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039442_VCaP_RNA_siSMARCA4_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039442/suppl/GSM4039442_VCaP_RNA_siSMARCA4_EtOH_rep1.bedGraph.gz,VCaP_RNA_siSMARCA4_EtOH_rep1,101399599,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603198,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSMARCA4_EtOH_rep2,GSM4039443,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSMARCA4, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039443_VCaP_RNA_siSMARCA4_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039443/suppl/GSM4039443_VCaP_RNA_siSMARCA4_EtOH_rep2.bedGraph.gz,VCaP_RNA_siSMARCA4_EtOH_rep2,100404780,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603237,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSMARCA4_EtOH_rep3,GSM4039444,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSMARCA4, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039444_VCaP_RNA_siSMARCA4_EtOH_rep3.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039444/suppl/GSM4039444_VCaP_RNA_siSMARCA4_EtOH_rep3.bedGraph.gz,VCaP_RNA_siSMARCA4_EtOH_rep3,98829391,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603236,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSMARCA4_DHT_rep1,GSM4039445,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSMARCA4, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039445_VCaP_RNA_siSMARCA4_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039445/suppl/GSM4039445_VCaP_RNA_siSMARCA4_DHT_rep1.bedGraph.gz,VCaP_RNA_siSMARCA4_DHT_rep1,86833717,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603235,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSMARCA4_DHT_rep2,GSM4039446,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSMARCA4, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039446_VCaP_RNA_siSMARCA4_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039446/suppl/GSM4039446_VCaP_RNA_siSMARCA4_DHT_rep2.bedGraph.gz,VCaP_RNA_siSMARCA4_DHT_rep2,103156164,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603230,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSMARCA4_DHT_rep3,GSM4039447,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSMARCA4, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039447_VCaP_RNA_siSMARCA4_DHT_rep3.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039447/suppl/GSM4039447_VCaP_RNA_siSMARCA4_DHT_rep3.bedGraph.gz,VCaP_RNA_siSMARCA4_DHT_rep3,114324850,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SMARCA4 (Dharmacon, L-010431-00, lot # 180816)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603229,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSIM2_EtOH_rep1,GSM4039448,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSIM2, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039448_VCaP_RNA_siSIM2_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039448/suppl/GSM4039448_VCaP_RNA_siSIM2_EtOH_rep1.bedGraph.gz,VCaP_RNA_siSIM2_EtOH_rep1,78484196,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603234,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSIM2_EtOH_rep2,GSM4039449,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSIM2, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039449_VCaP_RNA_siSIM2_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039449/suppl/GSM4039449_VCaP_RNA_siSIM2_EtOH_rep2.bedGraph.gz,VCaP_RNA_siSIM2_EtOH_rep2,53722190,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603233,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSIM2_EtOH_rep3,GSM4039450,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSIM2, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039450_VCaP_RNA_siSIM2_EtOH_rep3.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039450/suppl/GSM4039450_VCaP_RNA_siSIM2_EtOH_rep3.bedGraph.gz,VCaP_RNA_siSIM2_EtOH_rep3,63168477,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,EtOH vehicle,0.01%,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603232,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSIM2_DHT_rep1,GSM4039451,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSIM2, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039451_VCaP_RNA_siSIM2_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039451/suppl/GSM4039451_VCaP_RNA_siSIM2_DHT_rep1.bedGraph.gz,VCaP_RNA_siSIM2_DHT_rep1,65890618,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603231,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSIM2_DHT_rep2,GSM4039452,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSIM2, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039452_VCaP_RNA_siSIM2_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039452/suppl/GSM4039452_VCaP_RNA_siSIM2_DHT_rep2.bedGraph.gz,VCaP_RNA_siSIM2_DHT_rep2,62232992,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603228,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_RNA_siSIM2_DHT_rep3,GSM4039453,Public on Jun 03 2021,Aug 19 2019,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSIM2, RNA",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",polyA RNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,GSE136016,0,GSM4039453_VCaP_RNA_siSIM2_DHT_rep3.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4039nnn/GSM4039453/suppl/GSM4039453_VCaP_RNA_siSIM2_DHT_rep3.bedGraph.gz,VCaP_RNA_siSIM2_DHT_rep3,59364983,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,dihydrotestosterone,100 nM,6 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN12603227,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siNON_EtOH_rep1,GSM4790096,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siNON, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790096_VCaP_AR_siNON_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790096/suppl/GSM4790096_VCaP_AR_siNON_EtOH_rep1.bedGraph.gz,VCaP_AR_siNON_EtOH_rep1,335084216,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,EtOH vehicle,0.01%,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16183141,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siNON_EtOH_rep2,GSM4790097,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siNON, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790097_VCaP_AR_siNON_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790097/suppl/GSM4790097_VCaP_AR_siNON_EtOH_rep2.bedGraph.gz,VCaP_AR_siNON_EtOH_rep2,88337439,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,EtOH vehicle,0.01%,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16183140,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siNON_DHT_rep1,GSM4790098,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790098_VCaP_AR_siNON_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790098/suppl/GSM4790098_VCaP_AR_siNON_DHT_rep1.bedGraph.gz,VCaP_AR_siNON_DHT_rep1,133045476,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16183139,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siNON_DHT_rep2,GSM4790099,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790099_VCaP_AR_siNON_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790099/suppl/GSM4790099_VCaP_AR_siNON_DHT_rep2.bedGraph.gz,VCaP_AR_siNON_DHT_rep2,148188621,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16183138,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siSIM2_EtOH_rep1,GSM4790100,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSIM2, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790100_VCaP_AR_siSIM2_EtOH_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790100/suppl/GSM4790100_VCaP_AR_siSIM2_EtOH_rep1.bedGraph.gz,VCaP_AR_siSIM2_EtOH_rep1,164852076,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,EtOH vehicle,0.01%,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16183137,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siSIM2_EtOH_rep2,GSM4790101,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, vehicle, siSIM2, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790101_VCaP_AR_siSIM2_EtOH_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790101/suppl/GSM4790101_VCaP_AR_siSIM2_EtOH_rep2.bedGraph.gz,VCaP_AR_siSIM2_EtOH_rep2,124818720,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,EtOH vehicle,0.01%,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16183136,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siSIM2_DHT_rep1,GSM4790102,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSIM2, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790102_VCaP_AR_siSIM2_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790102/suppl/GSM4790102_VCaP_AR_siSIM2_DHT_rep1.bedGraph.gz,VCaP_AR_siSIM2_DHT_rep1,115697864,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16183135,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siSIM2_DHT_rep2,GSM4790103,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siSIM2, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790103_VCaP_AR_siSIM2_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790103/suppl/GSM4790103_VCaP_AR_siSIM2_DHT_rep2.bedGraph.gz,VCaP_AR_siSIM2_DHT_rep2,193872048,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against SIM2 (Dharmacon, L-008598-00, lot # 180323)",30 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16182374,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_input_siNON-siSIM2_rep1,GSM4790104,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, siNON-siSIM2 mix, control ChIP input",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790104_VCaP_input_siNON-siSIM2_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790104/suppl/GSM4790104_VCaP_input_siNON-siSIM2_rep1.bedGraph.gz,VCaP_input_siNON-siSIM2_rep1,590389516,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,Non-targeting control siRNA and ON-TARGETplus SMARTpool against SIM2,30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN16182373,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_input_siNON-siSIM2_rep2,GSM4790105,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, siNON-siSIM2 mix, control ChIP input",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790105_VCaP_input_siNON-siSIM2_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790105/suppl/GSM4790105_VCaP_input_siNON-siSIM2_rep2.bedGraph.gz,VCaP_input_siNON-siSIM2_rep2,130429030,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,Non-targeting control siRNA and ON-TARGETplus SMARTpool against SIM2,30 nM,72 h,EtOH vehicle,0.01%,1 h,NA,https://www.ncbi.nlm.nih.gov/biosample/SAMN16182372,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siNON_DHT_rep3,GSM4790106,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790106_VCaP_AR_siNON_DHT_rep3.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790106/suppl/GSM4790106_VCaP_AR_siNON_DHT_rep3.bedGraph.gz,VCaP_AR_siNON_DHT_rep3,142123544,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",60 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16182371,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siNON_DHT_rep4,GSM4790107,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siNON, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790107_VCaP_AR_siNON_DHT_rep4.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790107/suppl/GSM4790107_VCaP_AR_siNON_DHT_rep4.bedGraph.gz,VCaP_AR_siNON_DHT_rep4,153209115,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"Non-targeting control siRNA (Dharmacon, D-001810-10, lot # 2420873)",60 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16182370,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siFOXA1_DHT_rep1,GSM4790108,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siFOXA1, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790108_VCaP_AR_siFOXA1_DHT_rep1.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790108/suppl/GSM4790108_VCaP_AR_siFOXA1_DHT_rep1.bedGraph.gz,VCaP_AR_siFOXA1_DHT_rep1,219446417,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against FOXA1 (Dharmacon, L-010319-00, lot # 190627)",60 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16182368,https://www.ncbi.nlm.nih.gov/sra?term
GSE136016,VCaP_AR_siFOXA1_DHT_rep2,GSM4790109,Public on Jun 03 2021,Sep 16 2020,Jun 03 2021,SRA,1,"VCaP prostate cancer cells, DHT, siFOXA1, AR ChIP",Homo sapiens,9606,"VCaP cells were seeded at 70 % confluence in 10-cm plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 72 h and the cells were subsequently treated wither with vechicle (EtOH) or 100 nM of dihydrotestosterone for 1 h prior ChIP or ATAC. For RNA-seq the cells were treated with vehicle (EtOH) or 100 nM of dihydrotestosterone for 6 h prior RNA extraction. For siRNA treatments, the VCaP cells were transfected with siRNA using Lipofectamine RNAiMAX reagent 72 h before hormone treatments.","VCaP cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 µg/ml streptomycin, kept at 37 °C in a humidified 95% air/ 5% CO2 incubator.",genomic DNA,"For ChIP-seq, lysates were clarified from sonicated nuclei, and protein-DNA complexes were isolated with specified antibody. For ATAC-seq, 100 000 isolated nuclei were treated with 2.5 µl Nextera Tn5 Transposase from Nextera kit. For RNA-seq, RNA was extracted using Qiagen RNeasy Mini kit., For ChIP-seq, NEBNext Ultra II DNA Library Prep Kit; for ATAC-seq, Illumina Nextera DNA Library Prep Kit; for RNA-seq, NEBNext Poly(A) mRNA Magnetic Isolation Module kit and NEBNext Ultra II Directional RNA Library Prep kit.","Basecalls performed using CASAVA, FASTX-toolkit was used to trim low quality reads and sequence duplicates were collapsed, For ChIP-seq, the reads were aligned to human reference genome version hg38 by using Bowtie software version 0.12.9. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for SMARCA4 ChIP samples. EtOH treated AR ChIP sample from VCaP cells was used as control for AR ChIP samples., For ATAC-seq, the reads were aligned to human reference genome version hg38 by using Bowtie2 software version 2.3.4.1. Peaks were called using HOMER program version 4.9. with default parameters in findPeaks. Input sample from VCaP cells cells was used as control for ATAC samples., For RNA-seq, the reads were trimmed using trimmomatic version 0.33 and poly-A tails were removed using homerTools in HOMER. Contaminants reported in iGENOME were removed using Bowtie2 and remaining reads were mapped to human hg38 transcriptome and genome with tophat2 software version 2.0.31. Differential expression of genes was analyzed using DESeq2 using HOMER.",GPL18573,"Ville,,Paakinaho",villepaakinaho@gmail.com,Biomedicine,School of Medicine,University of Eastern Finland,Yliopistonranta 1E,Kuopio,70210,Finland,Illumina NextSeq 500,ChIP,genomic,ChIP-Seq,GSE136016,0,GSM4790109_VCaP_AR_siFOXA1_DHT_rep2.bedGraph.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4790nnn/GSM4790109/suppl/GSM4790109_VCaP_AR_siFOXA1_DHT_rep2.bedGraph.gz,VCaP_AR_siFOXA1_DHT_rep2,222864417,BEDGRAPH,,hg38,bedGraph (HOMER makeUCSCfile command) from alignment file.,VCaP,Vertebral Cancer of the Prostate,"ON-TARGETplus SMARTpool against FOXA1 (Dharmacon, L-010319-00, lot # 190627)",60 nM,72 h,dihydrotestosterone,100 nM,1 h,AR (rabbit antiserum; Karvonen et al. 1997),https://www.ncbi.nlm.nih.gov/biosample/SAMN16182367,https://www.ncbi.nlm.nih.gov/sra?term
